TECHLAB
Developer and manufacturer of in vitro enteric diagnostics focused on detection of intestinal pathogens, toxins, and fecal biomarkers. Services include assay development, contract research, and contract manufacturing; the company maintains ISO 13485 and MDSAP certification and FDA registration and publishes clinical evaluations and validation data.
Industries
Nr. of Employees
medium (51-250)
Patents
Fecal lactoferrin as a biomarker for determining disease severity and for treating infection in patients with Clostridium difficile disease
US-10295536-B2
View DetailsClostridium difficile dehydrogenase and toxin as a biomarker for monitoring infection in patients with clostridium difficile disease and differentiating carrier state from active disease
US-10295535-B2
View DetailsCell wall protein CwpV (CD0514) as a diagnostic marker for Clostridium difficile ribotype 027
US-9133527-B2
View DetailsCysteine protease Cwp84 (CD2787) as a diagnostic marker for Clostridium difficile
US-8790880-B2
View Details
Fecal lactoferrin as a biomarker for determining disease severity and for treating infection in patients with Clostridium difficile disease
US-10295536-B2
View DetailsClostridium difficile dehydrogenase and toxin as a biomarker for monitoring infection in patients with clostridium difficile disease and differentiating carrier state from active disease
US-10295535-B2
View DetailsCell wall protein CwpV (CD0514) as a diagnostic marker for Clostridium difficile ribotype 027
US-9133527-B2
View DetailsCysteine protease Cwp84 (CD2787) as a diagnostic marker for Clostridium difficile
US-8790880-B2
View DetailsProducts
C. DIFF QUIK CHEK COMPLETE
Rapid enzyme immunoassay that simultaneously detects glutamate dehydrogenase (GDH) antigen and toxins A & B in fecal specimens; intended as a combined screening and toxin detection test within a two-step diagnostic algorithm.
LEUKO EZ VUE
Lateral flow rapid test for fecal lactoferrin to indicate presence of fecal leukocytes and intestinal inflammation; provides results in approximately 10 minutes.
IBD-SCAN (quantitative lactoferrin ELISA)
Quantitative microplate ELISA for measuring fecal lactoferrin concentrations to aid assessment of intestinal inflammation and IBD activity.
E. HISTOLYTICA II (monoclonal antibody ELISA)
Monoclonal antibody-based ELISA for detection of Entamoeba histolytica adhesin antigen in fecal specimens; intended to distinguish E. histolytica from nonpathogenic Entamoeba species.
CRYPTOSPORIDIUM II (ELISA)
Second-generation ELISA for detection of Cryptosporidium oocyst antigen in fecal specimens, with visual or spectrophotometric read options.
DIFF CHEK
An enzyme immunoassay for use as a screening test to detect Clostridium difficile antigen, glutamate dehydrogenase, in fecal specimens from persons suspected of having C. difficile disease.
C. DIFF QUIK CHEK COMPLETE
Rapid enzyme immunoassay that simultaneously detects glutamate dehydrogenase (GDH) antigen and toxins A & B in fecal specimens; intended as a combined screening and toxin detection test within a two-step diagnostic algorithm.
LEUKO EZ VUE
Lateral flow rapid test for fecal lactoferrin to indicate presence of fecal leukocytes and intestinal inflammation; provides results in approximately 10 minutes.
IBD-SCAN (quantitative lactoferrin ELISA)
Quantitative microplate ELISA for measuring fecal lactoferrin concentrations to aid assessment of intestinal inflammation and IBD activity.
E. HISTOLYTICA II (monoclonal antibody ELISA)
Monoclonal antibody-based ELISA for detection of Entamoeba histolytica adhesin antigen in fecal specimens; intended to distinguish E. histolytica from nonpathogenic Entamoeba species.
CRYPTOSPORIDIUM II (ELISA)
Second-generation ELISA for detection of Cryptosporidium oocyst antigen in fecal specimens, with visual or spectrophotometric read options.
DIFF CHEK
An enzyme immunoassay for use as a screening test to detect Clostridium difficile antigen, glutamate dehydrogenase, in fecal specimens from persons suspected of having C. difficile disease.
Services
Manufacturing and production services for IVD test kits and components, provided from company manufacturing facilities.
Research services and collaborative R&D for industrial and academic partners focused on enteric disease markers, pathogen toxins, and assay development.
Manufacturing and production services for IVD test kits and components, provided from company manufacturing facilities.
Research services and collaborative R&D for industrial and academic partners focused on enteric disease markers, pathogen toxins, and assay development.
Expertise Areas
- Enteric diagnostics (intestinal pathogens and toxins)
- Parasitology diagnostics
- C. difficile diagnostic algorithm development
- Fecal biomarker testing and quantitation (lactoferrin)
Key Technologies
- Lateral flow immunoassay (rapid membrane tests)
- Microplate ELISA (qualitative and quantitative)
- Monoclonal antibody-based antigen detection
- Tissue culture toxin assays
News & Updates
Announcement that the combined GDH plus Toxin A/B test received first European IVDR certification.
Announcement describing the merger/acquisition by SSI Diagnostica Group and the integration of the company into a global diagnostics group.
Completion of a two-year business acceleration program focused on international sales development.
Announcement that the combined GDH plus Toxin A/B test received first European IVDR certification.
Announcement describing the merger/acquisition by SSI Diagnostica Group and the integration of the company into a global diagnostics group.
Completion of a two-year business acceleration program focused on international sales development.